Skip to content

MAPIALEJ

Active Private limited companyfounded 2019active for 7 yearsDrogenberg 20A, 3090 OverijseKBO/BCE: BE 0729.570.751
MAPIALEJ
Follow ReportCompare

Overview

Lifetime

6 annual accounts with figures on one time axis
peak €326,552 (2025)
€326,552▲ 23.4%
peak €258,584 (2025)
€258,584▲ 41.9%
peak €1,500 (2020)
€1,500unchanged
€430,739▲ 52.7%
Board1 name since 2019
1 directorFERNANDEZ VILLARREAL Wendy
Documentsfilings and deeds
10-10-2026163 days late
2025micro format
Gross margin from €264,622 to €326,552Result from €182,233 to €258,584Dividend €258,584Debts from €282,079 to €430,739Cash from €64,026 to €106,933

Key points

from the 2025 annual accounts

Equity

€1,500 =
1,5002024+258,584Profit-258,584Dividend1,5002025

MAPIALEJ paid out €258,584 in dividends. That is 100% of the 2025 profit.

Result

€258,584 ▲ 41.9%
€182,0002024€259,0002025

The result rose in 2025 from €182,233 to €258,584.

Debts

€430,739 100% of the balance sheet
Financial debts 10%Suppliers 18%Taxes and wages 5%Other 67%

Of this, €386,898 falls due within a year.

Investments

€24,821 2.2 × depreciation
2022202320242025

Green is investment, beige is depreciation. Machinery stands 465.3% higher than in 2024.

Filings

6 annual accounts 163 days
deadline202020222024

Latest accounts filed late: after the legal deadline.

Position in the sector

0.3%

Lower solvency than 95% of companies in human health. Sector median 63.0% · 20,767 companies.

Checked score

54
Fair
Financially stronger than 32% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%

A confirmed filing finding caps the score at 59.

Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: < 0.1%▼ -0.1 percentage points vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: 0.1%▲ +0.1 percentage points vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: < 0.1%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.4%▲ +0.4 percentage points vs 09-2026highest value 11-2026: 0.4%● unchanged vs 10-2026highest value

Financial strength
Average

25-1equity 0.3% of total assets
31+3short-term debt 89.5% · cash 24.7%
100=return on assets 59.8%

Score breakdown

raises risk
Capped at 59: a confirmed filing finding
Last filed accounts filed 163 days late; 1 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 0.89, cash €106,933
Figures for financial year 2025 (filed on 18-10-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 4% of them on solvency, 6% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-09-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 2,153 companies had the same profile as MAPIALEJ has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of MAPIALEJ itself: 0.4% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,153 companies, not a prediction for MAPIALEJ. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

No publishable credit limit, so credit only on tighter terms

Liquidity is insufficient, with a current ratio of 0.89 (0.5 in 2024), below 1. Short-term debt is 89.5% and cash 24.7% of total assets. 99.7% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
raises risk · Last filed accounts filed 163 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.89, cash €106,933
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 18-10-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20767 sector peers (2025).
NBB · sector comparison
Position among 20767 sector peers
Solvency
better than 5%
← weakest strongest →
raises risk · 2025 accounts filed 163 days late
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 10-10-2026, 163 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 6 filings
Deviation from the deadline
2025
163 days late
2024
36 days early
2023
12 days early
2022
41 days early
2021
40 days early
2020
32 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average on the deadline day. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 25 March (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end10-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

FV
FERNANDEZ VILLARREAL Wendy
Director, since 27-06-2019
  • FERNANDEZ VILLARREAL Wendy 100 sharesdeed of 02-07-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0729570751
Amendment of the articles Gazette deed
Registered office moved from Beauvechain to Overijse New registered office: Drogenberg 20A, 3090 Overijse · Previous registered office: Le Petit Champ, Nodebais 2, 1320 Beauvechain · Gazette deed
Incorporation Founding capital of €1,500, 100 shares · Founder: FERNANDEZ VILLARREAL Wendy · Appointment: FERNANDEZ VILLARREAL Wendy (director) · published on 02-07-2019 · Gazette deed
All 12 events

Comparable companies

same main activity, similar in size and age
Company
MAPIALEJ Overijse €432,239 €326,552 0.3% -
Anesthésie-Réanimation / Soins Intensifs Docteur Damien Henrard Wasseiges €444,719 €326,074 26.8% -
Dr. Eno Lavrysen Neurochirurgie Mortsel €413,674 €344,491 53.5% -
Nsthesiology Stoumont €457,832 €319,380 67.9% -
DR. JEROEN HUYS, ANESTHESIE-REANIMATIE Destelbergen €446,424 €302,852 9.2% -
DR. K. LEFEBVRE Sint-Niklaas €388,307 €327,263 0.5% -
Dr. Christophe Breusegem Lievegem €463,170 €308,878 5.9% -

These companies have the same main activity as MAPIALEJ: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €388,000 and €463,000, founded between 2018 and 2020.

Official details

Source: KBO
Status
Active since 28-06-2019Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.293.142.8511320 Beauvechain, since 28-06-2019
Financial year end
30 September
Peppol
Reachable since 24-06-2025
Company details

Annual accounts to 30-09-2025

€326,552▲ 23.4%
≈ €500,000estimated
€258,584▲ 41.9%
€1,500=
€432,239▲ 52.4%
Filing
Filed on 10-10-2026
Financials

Insights on MAPIALEJ

MAPIALEJ files the micro format. That format states no turnover. The gross margin rose from €82,519 in 2020 to €326,552 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 10-10-2026, 163 days late
€326,552
▲ 23.4%
€313,855
▲ 25.4%
€258,584
▲ 41.9%
-€43,612
▲ €87,833
0.3%
▼ 0.2 percentage points
0.89
▲ 0.39

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €500,000. Estimated: probably between €440,000 and €680,000.

Balance sheet

balance sheet total €432,239 on 30-09-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

0.3%

Lower than 95% of 20,767 companies in 2025.

0.89

Higher than 14% of 20,341 companies in 2025.

59.8%

Higher than 88% of 20,623 companies in 2025.

MAPIALEJ Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: top quarter · Equity: bottom quarter · Balance sheet total: middle half · Working capital: bottom quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020
Balance sheet: assets
20/58 432,239283,579151,992158,159100,031136,200
21/28 88,952153,15471,80177,7938,913988
22/27 88,857153,05971,70677,6978,817892
23 2,966525748972--
24 15,20720,7384,4645,3664,971892
26 70,684131,79666,49371,3593,846-
28 959595959595
29/58 343,287130,42580,19180,36691,119135,212
40/41 174,73241,70151,08117,20427,512-
40 94,6927,8114,81110,10024,520-
41 80,04033,89046,2697,1042,992-
54/58 106,93364,02629,11063,16263,606135,212
490/1 61,62124,698----
Balance sheet: equity and liabilities
10/49 432,239283,579151,992158,159100,031136,200
10/15 1,5001,5001,5001,5001,5001,500
10/11 1,5001,5001,5001,5001,5001,500
17/49 430,739282,079150,492156,65998,531134,700
17 43,43520,210----
170/4 43,43520,210----
42/48 386,898261,869150,492156,65998,531134,700
42 31,11117,50014,583---
44 76,11722,4633,4579,2319,08432,567
440/4 76,11722,4633,4579,2319,08432,567
45 21,08639,67438,08538,0077,79020,169
450/3 21,08639,67438,08538,0077,79020,169
47/48 258,584182,23394,367109,42081,65781,964
492/3 406-----
Income statement
9900 326,552264,622152,288150,84780,49182,519
630 11,44011,5518,7876,8802,2361,342
640/8 1,1242,85520,0254092,60156
66A 133-----
9901 313,855250,215123,477143,55975,65481,122
75/76B -1----
75 -1----
65/66B 6,1575,1501,2601,346558370
65 6,1575,1501,2601,346558370
9903 307,698245,066122,217142,21275,09680,751
67/77 49,11562,83327,85032,79212,62118,500
9904 258,584182,23394,367109,42062,47462,251
9905 258,584182,23394,367109,42062,47462,251
Appropriation of the result
9906 258,584182,23394,367109,42062,47462,251
694/7 258,584182,23394,367109,42062,47462,251
694 258,584182,23394,367109,42062,47462,251
Document PDFPDFPDFPDFPDFPDF

The notes to these accounts have 11 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 10-10-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-09-2025 micro format 10-10-2026 2026-00562218 PDF
30-09-2024 micro format 25-03-2025 2025-00053502 PDF
30-09-2023 micro format 18-04-2024 2024-00064486 PDF
30-09-2022 micro format 20-03-2023 2023-00044415 PDF
30-09-2021 micro format 21-03-2022 2022-08100520 PDF
30-09-2020 micro format 29-03-2021 2021-08700470 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020
325,295261,766132,264150,43877,89082,464
270,024193,784103,154116,30064,71063,593
24,82194,9492,79575,76010,1612,330
42,90734,916-34,052-444-71,606-
-43,612-131,444-70,301-76,293-7,413512
0.3%0.5%1.0%0.9%1.5%1.1%
0.890.500.530.510.921.00
----65.6989.80
59.8%64.3%62.1%69.2%62.5%45.7%
52.8450.83over 100over 100--

A ratio outside any meaningful range has been withheld (balance sheet total €432,239, equity €1,500).

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item30-09-202530-09-202430-09-202330-09-2022
Tangible fixed assets€24,821€94,949€2,795€75,760
€11,440€11,551€8,787€6,880

Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)

Insights on MAPIALEJ

The operating result for 2025 is 25% higher than in 2024 and the highest since 2020. It is the second rise in a row, after the fall in 2023.

Debt's share of the balance-sheet total rises from 99.5% to 99.7%. Debt is higher.

Board & ownership

Board

1 director, since incorporation
FERNANDEZ VILLARREAL Wendy
Director
since 27-06-2019 term without a fixed end
listed in the 2025 annual accounts
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 11 - Pouvoirs de l’organe d’administration - représentation de la société - gestion journalière S’il n’y a qu’un seul…”
deed of 02-07-2019

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
FERNANDEZ VILLARREAL Wendy
Director
Board
Mandates as a list
  • FERNANDEZ VILLARREAL Wendy
    • Director, from 27-06-2019 to date

See the board, name and registered office on a given date →

Control

Founder
FERNANDEZ VILLARREAL Wendy
This company
MAPIALEJ
Equity €1,500
Profit €258,584 in 2025

Capital

Contribution
€1,500
Shares
100
Contribution per share
€15
Equity per share
€15 in 2025
Source
deed of 02-07-2019

Articles of association

deed of 02-06-2021 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited

Shareholders

At incorporation deed of 02-07-2019 ↗

Capital transactions

Capital over time
  1. 02-06-2021 Capital stated in 2 deeds · 100 shares
  2. 02-07-2019 Incorporation · €1,500 · 100 shares

Network & group

No group

MAPIALEJ has no parent and no holdings in its annual accounts. FERNANDEZ VILLARREAL Wendy is the only director. MAPIALEJ shares no director with another company.

At the same address

Drogenberg 20A, 3090 Overijse · 1 other company
NOLUS
registered office since 07-05-2026
 founded in 2026
1037.758.557

Timeline

Timeline

12 events since 2019

Deadline for the 2026 accounts: 30-04-2027

2026
Annual accounts 2025 filed PDFmicro format · 163 days late
2025
Highest result from 2020 to 2025 net €258,584 ▲41.9% The operating result of €313,855 and the net result of €258,584 are both a record.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0729570751
Annual accounts 2024 filed PDFmicro format · 36 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 12 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 41 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 40 days before the deadline
2021
Amendment of the articles2 points ▸
  • Registered-office move, Flemish Region
  • 100 shares
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Registered office moved from Beauvechain to OverijseNew registered office: Drogenberg 20A, 3090 Overijse · Previous registered office: Le Petit Champ, Nodebais 2, 1320 Beauvechain2 points ▸
  • Registered-office move, Drogenberg 20A, 3090 Overijse
  • 100 shares
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2020 filed PDFmicro format · 32 days before the deadline
2019
IncorporationFounding capital of €1,500, 100 shares · Founder: FERNANDEZ VILLARREAL Wendy · Appointment: FERNANDEZ VILLARREAL Wendy (director) · published on 02-07-20194 points ▸

Open the deed in the Belgian Official Gazette

First establishment Le Petit Champ, Nodebais 2, Beauvechain

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

MAPIALEJ was incorporated on 28 June 2019 as a private limited company by one natural person, with a starting capital of €1,500.12 The registered office was moved to Overijse in 2021.3 Since 2019, FERNANDEZ VILLARREAL Wendy has served as director.4 Total assets rose from €136,200 in 2020 to €432,239 in 2025.5

  1. 1KBO register
  2. 2Belgian Official Gazette, 02-07-2019
  3. 3Belgian Official Gazette, 12-05-2021
  4. 4National Bank, annual accounts 2025
  5. 5National Bank, annual accounts 2020 and 2025

Company details

Identity

Enterprise number
0729.570.751
VAT number
BE 0729.570.751
Peppol ID
0208:0729570751
Other Peppol ID
9925:BE0729570751
Legal form
Private limited company
Status
Active, normal situation
Founded
28-06-2019
Financial year
ends on 30 September
Peppol
Reachable since 24-06-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
MAPIALEJ in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 02-06-2021 (in French)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 02-06-2021 (in French)

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
Codes under NACEBEL 2008
86220 Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“Aan de aandeelhouders die haar samenstellen,binnen de grenzen en met inachtneming van hun deontologie,de uitoefening en de organisatie van…”
21 activities
  1. Aan de aandeelhouders die haar samenstellen,binnen de grenzen en met inachtneming van hun deontologie,de uitoefening en de organisatie van de geneeskunst in het algemeen in België toe te laten
  2. Alle handelingen en raadplegingen te verrichten op het gebied van de anesthesiologie en de algologie
  3. Het verrichten van alle medische handelingen die met deze discipline verband houden
  4. Het beheer van alle middelen die bestemd zijn om de uitoefening ervan te verbeteren
  5. Met inachtneming van wettelijke en deontologische voorschriften,zowel in België als buitenland elke noodzakelijke activiteit voor maatschappelijk voorwerp,zonder medische bestemming te wijzigen
  6. Belang nemen in zaak,onderneming,vennootschap met zelfde,gelijkaardig of verwant voorwerp,die ontwikkeling kan bevorderen,onder voorbehoud van voorafgaande goedkeuring door bevoegde provinciale raad van de Orde der Artsen
  7. Alle financiële,roerende of onroerende verrichtingen die rechtstreeks of onrechtstreeks met doel betrekking hebben of enig voordeel voor ontwikkeling en rationeler beheer
  8. Ter beschikking stellen aan bestuurder(beheerder)-arts,zonder medische bestemming te wijzigen
  9. Geneeskunde beoefend door elke aandeelhouder-arts in naam en voor rekening van vennootschap
  10. Beroepsaansprakelijkheid elke aandeelhouder-arts onbeperkt
  11. Honoraria ingebracht door aandeelhoudende arts(en) geïnd in naam en voor rekening van vennootschap
  12. Iedere aandeelhouder-arts in volledige onafhankelijkheid met wettelijke en deontologische bepalingen,medisch geheim,diagnostische en therapeutische vrijheid,vrije keuze patiënt
  13. Alle handelingen die noodzakelijk en/of onontbeerlijk zijn voor vervulling voorwerp
  14. Alle handelingen behorend tot domeinen anesthesiologie en algologie
  15. Alle roerende en onroerende transacties betreffende medische lokalen
  16. Aankoop medische en niet-medische uitrusting
  17. Aanwerving administratief personeel,verplegend,uitoefenend of geroepen om te oefenen in vennootschap
  18. De leiding,de organisatie en het beheer van medische centra
  19. Multidisciplinaire wetenschappelijke artikelen en boeken te publiceren en te verspreiden
  20. Het organiseren van en deelnemen aan conferenties en seminars
  21. Het verstrekken van onderwijs met betrekking tot zijn medisch specialisme
deed of 02-06-2021 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Drogenberg 20A registered office 3090 Overijse
Le Petit Champ, Nodebais 2 1320 Beauvechain 28-06-2019 2.293.142.851
1 former office
  • 1320 Beauvechain until the deed of 12-05-2021

Buildings and parcels at the addresses

Ground area
2,276 m²
Buildings
227 m²
Volume, LiDAR
1,458 m³
Tallest building
10.2 m
Buildings to scale, each on its own parcel
177 m², 10.2 m 50 m², 9.6 m 177 m², 10.2 m 50 m², 9.6 m

Location

registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Parcels

Flanders 1 (50%) Wallonia 1 (50%)
Cadastral parcelRegionArea Buildings Height / floors
23544D0159/00T000Flanders1,622 m² 1 · 177 m² 10.2 m · 2
25073A0147/00Y000Wallonia654 m² 1 · 50 m² 9.6 m · 3

We would like to set cookies. That happens only with your consent. What we measure